Liver enzyme flares and occult hepatitis B in persons with chronic hepatitis C infection

Journal of Clinical Virology

Volumn 39, Issue 2, 2007, Pages 101-105

  Kannangai, Rajesh ^a   Vivekanandan, Perumal ^a   Netski, Dale ^a   Mehta, Shruti ^a   Kirk, Gregory D ^a   Thomas, David L ^a   Torbenson, Michael ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

ALT; AST; Hepatitis C; Occult hepatitis B

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; HEPATITIS B SURFACE ANTIGEN; IMMUNOGLOBULIN M; VIRUS DNA; VIRUS RNA;

ADULT; ARTICLE; CHRONIC HEPATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE EXACERBATION; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MALE; PRIORITY JOURNAL; SEROLOGY; VIRUS DETECTION; VIRUS REPLICATION;

ADULT; ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; COHORT STUDIES; FEMALE; HEPACIVIRUS; HEPATITIS B ANTIBODIES; HEPATITIS B CORE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; HUMANS; LIVER DISEASES; MALE; POLYMERASE CHAIN REACTION;

EID: 34248644858     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2007.03.006     Document Type: Article

References (22)

1. Chemin I., Zoulim F., Merle P., Arkhis A., Chevallier M., Kay A., et al. High incidence of hepatitis B infections among chronic hepatitis cases of unknown aetiology. J Hepatol 34 (2001) 447-454
2. Crespo J., Lozano J.L., Carte B., de las Heras B., de la Cruz F., and Pons-Romero F. Viral replication in patients with concomitant hepatitis B and C virus infections. Eur J Clin Microbiol Infect Dis 16 (1997) 445-451
3. Fujiwara K., Tanaka Y., Orito E., Ohno T., Kato T., Sugauchi F., et al. Lack of association between occult hepatitis B virus DNA viral load and aminotransferase levels in patients with hepatitis C virus-related chronic liver disease. J Gastroenterol Hepatol 19 (2004) 1343-1347
4. Fukuda R., Ishimura N., Niigaki M., Hamamoto S., Satoh S., Tanaka S., et al. Serologically silent hepatitis B virus coinfection in patients with hepatitis C virus-associated chronic liver disease: clinical and virological significance. J Med Virol 58 (1999) 201-207
5. Hou J., Wang Z., Cheng J., Lin Y., Lau G.K., Sun J., et al. Prevalence of naturally occurring surface gene variants of hepatitis B virus in nonimmunized surface antigen-negative Chinese carriers. Hepatology 34 (2001) 1027-1034
6. Hui CK, Lau E, Wu H, Monto A, Kim M, Luk JM, Lau GK, Wright TL. Fibrosis progression in chronic hepatitis C patients with occult hepatitis B co-infection. J Clin Virol 2005.
7. Kannangai R., Molmenti E., Arrazola L., Klein A., Choti M., Thomas D.L., et al. Occult hepatitis B viral DNA in liver carcinomas from a region with a low prevalence of chronic hepatitis B infection. J Viral Hepat 11 (2004) 297-301
8. Kazemi-Shirazi L., Petermann D., and Muller C. Hepatitis B virus DNA in sera and liver tissue of HBsAg negative patients with chronic hepatitis C. J Hepatol 33 (2000) 785-790
9. Komori M., Yuki N., Nagaoka T., Yamashiro M., Mochizuki K., Kaneko A., et al. Long-term clinical impact of occult hepatitis B virus infection in chronic hepatitis B patients. J Hepatol 35 (2001) 798-804
10. Levine O.S., Vlahov D., Brookmeyer R., Cohn S., and Nelson K.E. Differences in the incidence of hepatitis B and human immunodeficiency virus infections among injecting drug users. J Infect Dis 173 (1996) 579-583
11. Mehta S.H., Netski D., Sulkowski M.S., Strathdee S.A., Vlahov D., and Thomas D.L. Liver enzyme values in injection drug users with chronic hepatitis C. Dig Liver Dis 37 9 (2005) 674-680
12. Mels G.C., Bellati G., Leandro G., Brunetto M.R., Vicari O., Borzio M., et al. Fluctuations in viremia, aminotransferases and IgM antibody to hepatitis B core antigen in chronic hepatitis B patients with disease exacerbations. Liver 14 (1994) 175-181
13. Nirei K., Kaneko M., Moriyama M., and Arakawa Y. The clinical features of chronic hepatitis C are not affected by the coexistence of hepatitis B virus DNA in patients negative for hepatitis B surface antigen. Intervirology 43 (2000) 95-101
14. Silva C., Goncales N.S., Pereira J.S., Escanhoela C.A., Pavan M.H., and Goncales Jr. F.L. The influence of occult infection with hepatitis B virus on liver histology and response to interferon treatment in chronic hepatitis C patients. Braz J Infect Dis 8 (2004) 431-439
15. Takeuchi M., Fujimoto J., Niwamoto H., Yamamoto Y., and Okamoto E. Frequent detection of hepatitis B virus X-gene DNA in hepatocellular carcinoma and adjacent liver tissue in hepatitis B surface antigen-negative patients. Dig Dis Sci 42 (1997) 2264-2269
16. Thomas D.L., Astemborski J., Rai R.M., Anania F.A., Schaeffer M., Galai N., et al. The natural history of hepatitis C virus infection: host, viral, and environmental factors. JAMA 284 (2000) 450-456
17. Torbenson M., and Thomas D.L. Occult hepatitis B. Lancet Infect Dis 2 (2002) 479-486
18. Torbenson M., Kannangai R., Astemborski J., Strathdee S.A., Vlahov D., and Thomas D.L. High prevalence of occult hepatitis B in Baltimore injection drug users. Hepatology 39 (2004) 51-57
19. Toyoda H., Hayashi K., Murakami Y., Honda T., Katano Y., Nakano I., et al. Prevalence and clinical implications of occult hepatitis B viral infection in hemophilia patients in Japan. J Med Virol 73 (2004) 195-199
20. Vlahov D., Anthony J.C., Munoz A., Margolick J., Nelson K.E., Celentano D.D., et al. The ALIVE study, a longitudinal study of HIV-1 infection in intravenous drug users: description of methods and characteristics of participants. NIDA Res Monogr 109 (1991) 75-100
21. Zanella I., Rossini A., Domenighini D., Albertini A., and Cariani E. Quantitative analysis of hepatitis B virus DNA by real-lime amplification. Eur J Clin Microbiol Infect Dis 21 (2002) 22-26
22. Zignego A.L., Fontana R., Puliti S., Barbagli S., Monti M., Careccia G., et al. Relevance of inapparent coinfection by hepatitis B virus in alpha interferon-treated patients with hepatitis C virus chronic hepatitis. J Med Virol 51 (1997) 313-318